Nuvonis Technologies GmbH

Powering Reliable Vaccine and Vector Production;Welcome to Nuvonis Technologies. Nuvonis Technologies is your trusted partner in biotech, providing high-quality, innovative cell banks for vaccine and vector production. Our experienced team offers in-depth technical support across virus production processes, from vaccine strain improvement to comprehensive analytical services, ensuring a smooth and efficient development journey. GMP Cell Banks You Can Depend On: Nuvonis offers "ready to use" GMP Master and Working Cell Banks produced under serum- and animal-free conditions, guaranteeing quality and safety. Fully characterized, including end-of-production tumorigenicity testing, these cell banks are immediately available for your GMP manufacturing needs. Advancing Vaccine Production with Innovative Avian Cell Lines: Explore the potential of our continuous avian cell line, CCX, derived from primary quail cells. Available in both adherent (CCX.2C4) and suspension (CCX.E10) formats, our Avian Cell Banks provide a reliable and scalable alternative to traditional CEF or egg-based methods. Your Partner in Process Development Excellence: Rely on the Nuvonis team's extensive experience in developing and optimizing vaccine production processes. We offer a proprietary, high-efficiency virus purification process for superior vaccine purity, alongside tailored analytical services, analytical development, and seamless transfer of virus and viral vector assays (e.g., FFA).